Skip Navigation Links

Project Information

COMPARATIVE EFFECTIVENESS STUDY OF HORMONAL THERAPY IN ADVANCED PROSTATE CANCER

Agency:
AHRQ

HHS/Agency for Healthcare Research and Quality

Project Number:
1K01HS022915-01
Contact PI / Project Leader:
TSAI, HUEI-TING
Awardee Organization:
GEORGETOWN UNIVERSITY

Description

Abstract Text:
DESCRIPTION (provided by applicant): This K01 mentored award proposal aims to develop an independent investigator specializing in cancer comparative effectiveness research (CER) who combines patient-centered research, outcomes evaluation, and decision-analysis modeling in order to improve the quality of evidence-based practice in cancer care. I am an Assistant Professor of Oncology and a member of the Lombardi Comprehensive Cancer Center at Georgetown University. My pharmacy background and my research training in cancer epidemiology have motivated me to pursue a research career that contributes to high-quality cancer care in the United States. My career development plan consists of didactic education (formal coursework and training workshops) and a mentored research project with three research aims. This award is designed to fill gaps in my training and research experience, specifically in engaging stakeholders for research and developing Markov decision- analysis models to facilitate clinical decision making. Additionally, this award will provide training in methodology and analysis I have yet to receive in regards to assessing effectiveness, safety and patient- reported outcomes in an observational setting. My mentored research project is an exemplar CER project and aims to compare two hormonal therapy approaches: intermittent versus continuous administration of androgen deprivation therapy (ADT) in advanced prostate cancer. I have proposed this research project because ADT is used as primary treatment in prostate cancer control and its optimal administration remains unclear based on current evidence from clinical trials. I will leverage a longitudinal cohort created through collaboration with a large integrated health plan, which includes rich cancer registry information merged with comprehensive electronic clinical encounter data, pharmaceutical data, and laboratory values. I will compare all-cause and disease-specific survival (Aim1: effectiveness) and risk of serious side effects (Aim 2: safety) of intermittent versus continuous ADT. I then will integrate Aims 1 and 2 findings with published data on patients' preference into a decision-analysis model to project patients' quality-adjusted-life-expectancy on these two types of ADT (Aim 3). Findings from the proposed study will contribute knowledge not provided by existing clinical trials. I will conduct this mentored award in the established and supportive training environment of the Lombardi Comprehensive Cancer Center with an expert team of researchers in health services research, clinical medicine, health economics, and biostatistics. I also will seek guidance from an advisory board consisting of patients, caregivers, physicians, and a behavioral researcher about how best to communicate study findings and shape my future research to address the needs of cancer patients and survivors. After completion of this mentored award, I will have acquired expertise in evidence generation and integration of outcomes important to clinical decision-making. I will also be well prepared to apply the cancer CER expertise gained from this research experience to a broad array of emerging and novel treatment interventions in cancer care.
Project Terms:
Address; Adverse effects; Androgens; Award; base; Behavioral; Biometry; cancer care; Cancer Control; cancer epidemiology; Cancer Patient; career; career development; Caregivers; Clinical; clinical decision-making; Clinical Medicine; Clinical Trials; cohort; Collaborations; comparative effectiveness; Comprehensive Cancer Center; Data; Decision Analysis; deprivation; design; Development Plans; didactic education; Disease; Educational workshop; Effectiveness; effectiveness research; Electronics; Environment; Evaluation; Evidence based practice; experience; Future; Generations; health economics; Health Planning; Health Services Research; hormone therapy; improved; Intervention; Knowledge; Laboratories; Life Expectancy; Malignant neoplasm of prostate; Malignant Neoplasms; member; Mentors; Methodology; Modeling; neoplasm registry; novel; oncology; Outcome; Outcomes Research; patient oriented; Patient Outcomes Assessments; Patient Preferences; Patients; Pharmacologic Substance; Pharmacy facility; Physicians; professor; Publishing; Research; Research Personnel; Research Project Grants; Research Training; Risk; Safety; Shapes; Survivors; Training; United States; Universities

Details

Contact PI / Project Leader Information:
Name:  TSAI, HUEI-TING
Other PI Information:
Not Applicable
Awardee Organization:
Name:  GEORGETOWN UNIVERSITY
City:  WASHINGTON    
Country:  UNITED STATES
Congressional District:
State Code:  DC
District:  98
Other Information:
Fiscal Year: 2014
Award Notice Date: 30-Apr-2014
DUNS Number: 049515844
Project Start Date: 01-Jul-2014
Budget Start Date: 01-Jul-2014
CFDA Code: 226
Project End Date: 30-Jun-2017
Budget End Date: 30-Jun-2015
Agency: ?

Agency: The entity responsible for the administering of a research grant, project, or contract. This may represent a federal department, agency, or sub-agency (institute or center). Details on agencies in Federal RePORTER can be found in the FAQ page.

HHS/Agency for Healthcare Research and Quality
Project Funding Information for 2014:
Year Agency

Agency: The entity responsible for the administering of a research grant, project, or contract. This may represent a federal department, agency, or sub-agency (institute or center). Details on agencies in Federal RePORTER can be found in the FAQ page.

FY Total Cost
2014 AHRQ

HHS/Agency for Healthcare Research and Quality

$136,669

Results

i

It is important to recognize, and consider in any interpretation of Federal RePORTER data, that the publication and patent information cannot be associated with any particular year of a research project. The lag between research being conducted and the availability of its results in a publication or patent award varies substantially. For that reason, it's difficult, if not impossible, to associate a publication or patent with any specific year of the project. Likewise, it is not possible to associate a publication or patent with any particular supplement to a research project or a particular subproject of a multi-project grant.

ABOUT FEDERAL REPORTER RESULTS

Publications: i

Click on the column header to sort the results

PubMed = PubMed PubMed Central = PubMed Central Google Scholar = Google Scholar

Patents: i

Click on the column header to sort the results

Similar Projects

Download Adobe Acrobat Reader:Adobe Acrobat VERSION: 3.41.0 Release Notes
Back to Top